Form D · Other
Advera Health Analytics, Inc.
Santa Rosa, CA · CIK 0001757350
Offering snapshot reported Nov 28, 2018 · SEC filing
- Reported sold
- $700K Offering amount: $700K
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 28, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 28, 2018 | Initial | $700,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-326663
Source: Form D, filed Nov 28, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jonathan De Pass | Director |
| Hoa Duong | Director, Executive |
| Robert Kyle | Director, Executive |
| Brian M. Overstreet | Director, Executive |
| Michael Tansey | Director |
Issuer details
Industry: Other (See others in industry)
Address:
427 Mendocino Avenue Suite 150
Santa Rosa, CA, 95401
Santa Rosa, CA, 95401